Skip to main content
. 2021 Feb 4;11:607261. doi: 10.3389/fimmu.2020.607261

Table 2.

Clinical features of different histopathological types of MPO-ANCA-GN.

Focal (n = 32) Mixed (n = 26) Crescentic (n = 29) Sclerotic (n = 25) p
Male (n, %) 17 (53.1%) 12 (46.2%) 15 (51.7%) 12 (48.0%) 0.95
Age(years) 65.0 (49.5, 71.8) 64.3±10.2 64.0 (53.0, 66.5) 66.0 (55.5, 73.5) 0.676
Duration of renal disease (months) 2.0 (1.0, 3.0) 1.0 (0.95, 3.0) 1.0 (1.0, 2.0) 1.0 (1.0, 4.5) 0.508
BVAS at diagnosis 17.7 ± 3.6 18.0 (18.0, 21.3) 19.1 ± 2.8 18.0 (17.0, 19.0) 0.172
Initial RRT (n, %) 4 (12.5%) 13 (50.0%) b 13 (44.8%) b 17 (68.0%) b <0.001
DFPP (n, %) 2 (6.3%) 6 (23.1%) 7 (24.1%) 8 (32.0%) 0.096
Serum Creatinine (μmol/L) 157.2 (85.5, 229.1) 306.1 (185.2, 666.7) b 430.6 (211.3.2, 670.0) a 557.5 ± 306.6 a <0.001
eGFR (mL/min/1.73m2) 41.3 (27.8, 94.8) 18.6 (7.2, 34.7) b 12.1 (6.6, 28.7) a 8.9 (5.4, 17.7) a <0.001
CRP (mg/L) 76.4 (16.4, 119.8) 27.9 (14.7, 71.2) 49.9 (14.9, 104.3) 26.8 (5.7, 76.4) 0.098
RF (IU/mL) 29.9 (10.6, 152.5) 12.5 (10.7, 36.7) 11.1 (10.1, 31.9) c 10.1 (9.5, 11.0) a 0.004
Serum Albumin (g/L) 29.7 ± 8.2 29.7 ± 4.3 28.1 ± 4.3 28.3 ± 4.8 0.543
Hemoglobin (g/L) 91.3 ± 19.4 88.0 ± 23.9 76.0 (67.5, 88.0) b 79.0 (68.0, 82.0) 0.034
Urine red blood cell (/μL) 96.3 (27.0, 207.6) 230.0 (107.7, 1087.8) 358.9 (61.7, 929.7) b 297.2 (114.8, 648.7) b 0.014
urine protein (g/24h) 0.92 (0.58, 1.67) 1.18 (0.56, 4.40) 1.63 (1.05, 2.57) 1.55 (0.44, 2.78) 0.312
Extrarenal involvement (n, %)
 Lung 16 (50.0) 14 (53.8) 17 (58.6) 14 (56.0) 0.922
 ENT 7 (21.9) 12 (46.2) 11 (37.9) 9 (36.0) 0.264
 Skin 3 (9.4) 5 (19.2) 4 (13.8) 3 (12.0) 0.740
 Abdominal 3 (9.4) 2 (7.7) 0 1 (4.0) 0.387
 Fever 4 (12.5) 5 (19.2) 3 (10.3) 6 (24.0) 0.500
a

Focal versus mixed, crescentic, and sclerotic (p < 0.01).

b

Focal versus mixed, crescentic, and sclerotic (p < 0.05).

c

Mixed versus crescentic and sclerotic (p < 0.05).